Charles Warden
QuietNamed in filings at Versant SideOn the current fund
- Board seats filed
- 8
- Named on a board
- 0
all filings on record
Named in filings at Versant SideOn the current fund
all filings on record
last 24 months
from a verified or cited source
| OCULAR THERAPEUTIX | Biotech & pharma | March 2019 | None on file |
| Iantech | Medical devices | June 2017 | None on file |
| AcuFocus | Medical devices | August 2014 | SV Life Sciences, Versant Venture Capital, Versant Venture V AIV |
| Cotera | AI & machine learning | June 2014 | Domain Partners |
| Ceterix Orthopaedics | Medical devices | December 2012 | New Enterprise Associates, Pivotal bioVenture Partners, Versant Venture Capital, Versant Venture V AIV, Versant Voyageurs, Westlake Biopartners |
| GLUMETRICS | Medical devices | March 2012 | Lightstone Ventures |
| Wavetec Vision Systems | Medical devices | February 2012 | None on file |
| TWELVE | Climate & energy | January 2012 | Domain Partners, Lightstone Ventures, Qiming U.S Healthcare |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Charles Warden on the board, based on 8 filed seats with a verified or cited source.